DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors
Statins are lipid-lowering drugs widely used in the management of vascular diseases. Clinical and experimental evidence suggest that statins improve endothelial function by both cholesterol-lowering-dependent and -independent mechanisms. We have previously shown that endothelial dysfunction induced by risk factors and proinflammatory cytokines is associated with down-regulation of lysyl oxidase (LOX), a key enzyme modulating extracellular matrix maturation and vascular integrity. Our aim was to analyse whether statins could normalize LOX expression impaired by proatherogenic risk factors., This work was supported by Sociedad Española de Cardiología (SEC); Fondo de Investigaciones Sanitarias [FIS061480]; Red Temática de Investigación Cardiovascular RECAVA [RD06/0014/0027] from Instituto de Salud Carlos III; and Ministerio de Educación y Ciencia [SAF2006-07378, SAF2006-10009]., Peer reviewed
Project:
MEC SAF2006-07378
,
MEC SAF2006-10009
DOI: http://hdl.handle.net/10261/413514, https://api.elsevier.com/content/abstract/scopus_id/67651124960
HANDLE: http://hdl.handle.net/10261/413514, https://api.elsevier.com/content/abstract/scopus_id/67651124960